The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.

Source:http://linkedlifedata.com/resource/pubmed/id/14760188

Download in:

View as

General Info

PMID
14760188